Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Psychiatry indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Persistent physical symptoms and positive formulation

Psychiatry · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
New instability or changed symptoms

A previous formulation of persistent physical symptoms must never override acute physiology, a materially different symptom, objective deterioration, self-harm risk or inability to meet basic needs.

Action: Assess ABCDE and the new presentation on its merits, use the relevant acute pathway, obtain collateral information where appropriate, and document why immediate investigation, urgent referral or a planned safety-net is proportionate.

Overview

Recognise persistent physical symptoms without dismissing physical disease, construct a credible biopsychosocial formulation, and coordinate proportionate care that restores function while preserving safety-netting.

Persistent physical symptoms describe bodily experiences that continue, cause distress or disability, and are not wholly accounted for by recognised disease pathology. The term is descriptive rather than a verdict about cause. Symptoms may include pain, fatigue, dizziness, gastrointestinal disturbance, palpitations or sensory complaints, and several mechanisms may operate together. A clinician should validate the experience while retaining diagnostic curiosity.

A positive formulation explains why symptoms may persist. Predisposing factors can include previous illness or adversity; precipitating factors can include infection, injury or major stress; perpetuating processes may include disrupted sleep, autonomic arousal, boom-and-bust activity, threat monitoring, medication effects and repeated alarming investigations; protective factors include supportive relationships, valued roles and existing coping skills. The formulation is provisional, shared and revised when evidence changes.

Aetiology

01

Mixed biological contributors

Infection, injury, chronic disease, medicine effects, autonomic change, sleep disruption and altered sensory processing can combine without one factor accounting for the whole presentation.

02

Learning and context

Previous illness, frightening healthcare experiences, adversity, workplace demands and family responses can shape symptom expectations, avoidance and help seeking without making symptoms deliberate.

Pathophysiology

  1. 1
    Sensory amplification

    Increased attention and predictive threat processing can raise the salience of bodily signals, so ordinary or post-illness sensations are experienced as more intense and dangerous.

  2. 2
    Autonomic reinforcement

    Fear can increase heart rate, breathing changes, dizziness and muscle tension; these sensations then provide apparently physical confirmation of the original threat.

  3. 3
    Activity instability

    Alternation between overexertion and prolonged rest can reduce conditioning, disturb sleep and make normal exertional sensations less predictable and more alarming.

Clinical features and red flags

Persistent multisystem burden

Symptoms recur or continue across weeks or months, often affecting several bodily systems and daily activities more than isolated test abnormalities would predict.

Attention and arousal loop

Threat-focused monitoring, repeated checking and autonomic arousal can amplify ordinary sensations, which then appear to confirm the feared explanation and sustain further vigilance.

Boom-and-bust activity

Periods of overactivity on better days followed by prolonged recovery can produce an unstable baseline, deconditioning and understandable loss of confidence in movement.

Healthcare fragmentation

Multiple unscheduled contacts, duplicated tests, inconsistent explanations and medicine accumulation suggest that lack of coordination may itself be maintaining distress and risk.

Coexisting disease

A recognised long-term condition may explain part of the presentation while sleep, sensitisation, mood or behavioural responses account for additional disability.

Red flags requiring action

  • Abnormal vital signs, collapse, acute confusion, focal neurology or severe unremitting pain require prompt medical assessment.
  • Progressive weight loss, persistent fever, bleeding, a new mass or reproducible objective deficit needs investigation for physical disease.
  • A substantial change in the pattern, severity or context of established symptoms should not be attributed automatically to the existing formulation.

Investigations

  1. 01
    Chronology and records reviewFirst step
    Why
    Map onset, change, previous diagnoses, completed tests, treatments and the patient's feared explanation before selecting further investigation.
    Interpretation and limitations
    A stable pattern with repeated adequate negative evaluation supports a planned formulation; missing results, new features or prior uncertainty may identify a focused clinical question.
  2. 02
    Presentation-directed examination
    Why
    Identify objective signs and assess the relevant system rather than performing indiscriminate examination solely to demonstrate normality.
    Interpretation and limitations
    Normal findings can support reassurance only in context; abnormal or progressive findings require an appropriately revised differential and plan.
  3. 03
    Targeted baseline testing
    Why
    Use history and examination to decide whether a limited test could identify a plausible, treatable alternative or establish a useful baseline.
    Interpretation and limitations
    Before requesting, specify how positive, negative and incidental results would change management; avoid recurring panels that answer no new question.
  4. 04
    Functional and symptom measures
    Why
    Record participation, sleep, symptom interference, mood and patient-defined goals; a PHQ-15 may structure symptom burden in relevant services.
    Interpretation and limitations
    Scores track domains over time but

Differential diagnosis

01

Unrecognised physical disease

New inflammatory, endocrine, neurological, malignant or cardiopulmonary illness may initially be nonspecific; chronology, objective change and focused reassessment distinguish it from a stable pattern.

02

Medicine or substance effect

Sedation, dizziness, gastrointestinal symptoms, withdrawal and interactions can arise from prescribed medicines, alcohol, recreational drugs, caffeine or non-prescribed preparations.

03

Mental disorder with somatic symptoms

Depression, panic, post-traumatic stress and health anxiety may produce or amplify bodily symptoms and can coexist with persistent symptom mechanisms or recognised disease.

Management

01Initial consultationValidate and formulateFirst stepPersistent symptoms impair function despite prior assessment or treatment.+
  1. 1Acknowledge the symptoms and their impact, ask what the person fears or hopes the assessment will explain, and clarify the agenda.
  2. 2Summarise physical findings, coexisting disease and uncertainty, then offer a mechanism-based formulation using the person's own examples and language.
  3. 3Agree one or two functional goals, a focused clinical plan, who coordinates it and when the formulation will be reviewed.
02Planned recoveryRestore sustainable functionImmediate dangerous causes have been addressed and the person accepts a shared working explanation.+
  1. 1Stabilise sleep and daily rhythm, then establish a manageable activity baseline that avoids repeated overexertion and prolonged withdrawal.
  2. 2

Complications

01

Functional decline

Avoidance, deconditioning and loss of routine can progressively restrict mobility, education, employment, relationships and independent self-care even without worsening tissue pathology.

02

Treatment-related harm

Duplicated imaging, invasive procedures, incidental findings, polypharmacy and conflicting advice can cause direct harm while increasing uncertainty and dependence on urgent services.

03

Diagnostic overshadowing

Once a functional or persistent-symptom label is recorded, clinicians may under-assess new disease, mental-health deterioration, abuse or adverse medicine effects.

Monitoring and follow-up

  • Review agreed functional outcomes such as attendance, self-care, mobility, sleep regularity and return to valued activity, not symptom scores alone.
  • Record new red flags, objective change and any remaining diagnostic uncertainty at each clinically significant review.
  • Track medicine benefit, sedation, constipation, dependence, withdrawal symptoms and duplicate prescribing across services.
  • Monitor mood, hopelessness, self-harm risk, alcohol or drug use, caring responsibilities and safeguarding concerns proportionately.
  • Audit urgent attendance, repeated testing and specialist contacts as signals that the formulation or access plan may need revision.

Special situations

Validation is specific

Name the symptom, observed impact and remaining uncertainty. Generic reassurance such as saying every test is normal may sound dismissive and rarely supplies a usable explanation.

Formulation is testable

A good formulation generates small experiments, such as pacing activity or reducing checking, and is revised if the predicted change does not occur.

Psychological does not mean unreal

Attention, expectation, learning and autonomic regulation are embodied processes. Discussing them alongside tissue pathology prevents an unhelpful mind-versus-body split.

Incidental findings need explanation

Name whether an imaging or laboratory abnormality explains the symptom, requires surveillance or needs no action; unexplained incidental results can otherwise generate further cascades.

Recovery can precede relief

Increasing participation while symptoms remain is not disbelief or therapeutic failure; improved function can reduce threat and create conditions in which symptom burden later falls.

Common pitfalls

  1. 01

    Using medically unexplained as shorthand for no disease, no distress or no need for further clinical review.

  2. 02

    Ordering a broad test panel without defining what question it answers or how each possible result would alter care.

  3. 03

    Presenting psychological therapy as the destination after medicine has failed instead of one integrated component of treatment.

  4. 04

    Assuming inconsistent severity proves fabrication; fluctuation is common and should be described before its mechanism is inferred.

  5. 05

    Changing several medicines and rehabilitation targets simultaneously, making benefit, adverse effects and withdrawal impossible to interpret.

  6. 06

    Discharging from repeated specialties without a named coordinator, accessible safety-net or shared record of completed assessment.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
PsychiatryOriginal SBA

Positive symptom formulation

A woman has disabling fatigue and dizziness after an infection; examination and focused investigations are reassuring, but she fears clinicians think the symptoms are invented. What is the best next consultation step?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Psychiatry topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHS England persistent physical symptoms pathwayIntegrated physical and psychological assessment, shared treatment planning and NHS Talking Therapies access.
  • NICE NG193 chronic pain recommendationsPerson-centred assessment, chronic primary pain, psychological therapies and avoidance of low-value drug initiation.
  • NICE NG56 multimorbidity recommendationsCoordination, reduction of treatment burden and individualised management plans across conditions.
  • NHS Talking Therapies manualCurrent service definitions and pathway expectations for long-term conditions and persistent physical symptoms.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Assessment is neither exhaustive exclusion nor premature closure. Establish the chronology, previous baseline, functional consequences, patient concerns, treatments and investigations already completed. Examine according to the presentation and seek objective inconsistencies or abnormalities without turning the encounter into a test of credibility. Review mental health, substances, trauma sensitively, occupational demands and safeguarding, while making clear that these questions are routine and do not negate physical symptoms.

Management aims to reduce symptom interference and treatment burden. A coherent explanation, graded restoration of sustainable activity, sleep support, rehabilitation and appropriately selected psychological therapy can be combined with care for coexisting disease. Success may initially mean improved participation, fewer crises and greater confidence in self-management rather than immediate symptom disappearance.

Continuity is therapeutic. A planned review allows clinicians to notice genuine change, prevents each attendance restarting the whole diagnostic process and gives the person a reliable route back to assessment. The record should contain a concise formulation, tests already completed, outstanding uncertainties, medicine decisions, functional goals and specific red flags so that other services do not mistake coordination for refusal of care.

Key points

  • Persistent physical symptoms are real and potentially disabling even when available pathology does not fully explain their pattern or burden.
  • Use a positive formulation that links symptoms, nervous-system responses, attention, activity, sleep, mood and social context without implying that symptoms are imagined.
  • Review previous records and investigations before ordering more tests, but investigate new red flags and meaningful clinical change in the usual way.
  • Known physical disease and persistent symptom mechanisms can coexist; neither diagnosis cancels the other.
  • Agree one coordinated plan with named clinical responsibility, functional goals, scheduled review and explicit thresholds for earlier reassessment.
  • Psychological treatment is offered to improve coping, distress and function, not as proof that symptoms are psychiatric or fabricated.
  • Avoid abrupt withdrawal of long-term medicines; review benefit and harm collaboratively and taper dependence-forming drugs when indicated.
  • Repeated reassurance without a shared explanation is short-lived and can reinforce checking, uncertainty and fragmented attendance.
  • Suicidal intent, severe self-neglect, medication toxicity, domestic abuse or exploitation requires urgent risk and safeguarding action.
    • do not
    prove a psychogenic cause, exclude disease or replace a collaborative clinical assessment.
  • 05
    Medicine reconciliation
    Why
    Identify prescribed, over-the-counter and non-prescribed substances that may cause symptoms, interact or create withdrawal risk.
    Interpretation and limitations
    Temporal associations and limited benefit support a shared review, but long-term opioids, benzodiazepines, gabapentinoids or antidepressants may require gradual rather than abrupt change.
    • Treat coexisting disease, mood and substance problems while considering physiotherapy, occupational therapy or NHS Talking Therapies according to need and preference.
  • 3Review function, adverse treatment effects and confidence as well as symptoms, adjusting goals gradually rather than promising rapid eradication.
    • 03Clinical changeReopen the differentialNew red flags, objective findings or a material departure from the documented pattern develops.+
    1. 1Describe exactly what has changed and assess urgency without using the prior formulation as an exclusion criterion.
    2. 2Investigate or refer to answer the new clinical question, comparing results with the previous baseline and avoiding unrelated duplicated testing.
    3. 3Update the shared formulation and safety-net, explaining whether the new information changes disease management, symptom management or both.